Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

This is an International, Prospective, Non-interventional Study, Company Sponsored, Multi-center Study. Patients Undergo Coronary Angiography or PCI Procedure With Ultravist. The Primary Objective is to Evaluate the Safety and Tolerability.

NCT01206257 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01206257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01206257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
This is an International, Prospective, Non-interventional Study, Company Sponsored, Multi-center Study. Patients Undergo Coronary Angiography or PCI Procedure With Ultravist. The Primary Objective is to Evaluate the Safety and Tolerability.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
September 30, 2011
Enrollment
17,513 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiocardiography